Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION)
LIU Yun, SUN Xiu-zhen, XU Jing. et al. Expression, Purification and Structure Prediction of Hum s1, a Major Allergen of Humulus Scandens[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(1): 14-18.
Citation: LIU Yun, SUN Xiu-zhen, XU Jing. et al. Expression, Purification and Structure Prediction of Hum s1, a Major Allergen of Humulus Scandens[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(1): 14-18.

Expression, Purification and Structure Prediction of Hum s1, a Major Allergen of Humulus Scandens

  • Objective Hum s1, a major allergen of Humulus Scandens, was cloned, expressed and purified. Its protein structure and function was predicted and analyzed, which provided a foundation for further studies into the diagnostic and therapeutic efficacy of the recombinant allergen. Methods The target gene was amplified by PCR and sub-cloned into the expression vector pET32a throughKpn Ⅰ/Xho Ⅰsite. The recombinant plasmid was transformed into clone strainE.coliDH5α. The positive recombinant plasmid identified by PCR was transformed into the expression strainE.coliBL-21. The expressed fusion protein was induced by IPTG, and purified using fast protein liquid chromatography. The structure and function of the protein was predicted and analyzed. Results Prokaryotic expression plasmid pET32a-G2 was constructed successfully. Hum s1 was expressed and purified. The purity of expressed fusion protein exceeded 90%. It has three potential antigen epitopes and two EF-hand structural domains. A three-dimensional model was successfully constructed. The recombinant protein was proved to have immunological activity, with ELESA showing good attachment to sera samples of patients who were allergic to Humulus Scandens. Conclusion Prokaryotic expression vector ofHum s1 was successfully constructed. The recombinant protein was expressed and purified, with its epitope and three-dimensional model being predicted by bioinformatics. The study provided a basis for further development of recombinant vaccines.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return